We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+13.86%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.41B
AUM Growth
+$274M
(+13%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
4.66%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
158
New
13
Increased
40
Reduced
8
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dianthus Therapeutics
DNTH
|
+$31.6M |
| 2 |
TECX
Tectonic Therapeutic
TECX
|
+$27.9M |
| 3 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$22.5M |
| 4 |
Palo Alto Networks
PANW
|
+$20.8M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
+$52M |
| 2 |
CAFD
8point3 Energy Partners LP
CAFD
|
+$18.9M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$18M |
| 4 |
Twilio
TWLO
|
+$12.5M |
| 5 |
Snap-on
SNA
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.26% |
| 2 | Technology | 16.99% |
| 3 | Consumer Discretionary | 12.15% |
| 4 | Industrials | 8.07% |
| 5 | Utilities | 2.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Steel Dynamics
STLD
$36.2B
| $34.6M | 1.44% |
754,000
| – | – |
|
27
Lear
LEA
$7.33B
| $34.2M | 1.42% |
184,000
| – | – |
|
28
ASML
ASML
$634B
| $34.1M | 1.41% |
172,000
| – | – |
|
29
Trade Desk
TTD
$8.59B
| $33.8M | 1.4% |
3,600,000
| – | – |
|
|
OPLN
30
Openlane
OPLN
$4.29B
| $33.4M | 1.39% |
1,611,620
| – | – |
|
31
Crown Castle
CCI
$33.4B
| $32.9M | 1.36% |
305,000
| – | – |
|
32
FIVE9
FIVN
$2.12B
| $30.9M | 1.28% |
894,000
| – | – |
|
|
WBC
33
DELISTED
WABCO HOLDINGS INC.
WBC
| $29.9M | 1.24% |
255,600
| – | – |
|
|
34
Dianthus Therapeutics
DNTH
$6.16B
| $29.5M | 1.22% |
+139,881
| New | +$31.6M |
|
|
CELG
35
DELISTED
Celgene Corp
CELG
| $28.7M | 1.19% |
361,000
| – | – |
|
36
uniQure
QURE
$2.93B
| $28.5M | 1.18% |
754,050
+419,050
| +125% | +$13.4M |
|
|
IDTI
37
DELISTED
Integrated Device Technology I
IDTI
| $26.3M | 1.09% |
826,000
| – | – |
|
|
XLRN
38
DELISTED
Acceleron Pharma
XLRN
| $25.7M | 1.07% |
529,900
| – | – |
|
|
TECX
39
Tectonic Therapeutic
TECX
$538M
| $25.6M | 1.06% |
+77,408
| New | +$27.9M |
|
|
ELLI
40
DELISTED
Ellie Mae Inc
ELLI
| $25.1M | 1.04% |
242,000
| – | – |
|
41
Roper Technologies
ROP
$38.5B
| $24M | 1% |
87,000
+28,000
| +47% | +$7.72M |
|
42
Aptiv
APTV
$12.3B
| $23.8M | 0.99% |
259,200
+62,700
| +32% | +$5.85M |
|
43
Lennox International
LII
$14.5B
| $23.6M | 0.98% |
118,000
| – | – |
|
44
Arrow Electronics
ARW
$10.9B
| $22.2M | 0.92% |
295,000
| – | – |
|
|
ZGNX
45
DELISTED
Zogenix, Inc.
ZGNX
| $21.1M | 0.88% |
478,000
+213,000
| +80% | +$8.78M |
|
46
JELD-WEN Holding
JELD
$117M
| $20M | 0.83% |
700,000
+55,900
| +9% | +$1.62M |
|
|
PEGI
47
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $19.9M | 0.83% |
1,063,000
+28,500
| +3% | +$519K |
|
48
Veracyte
VCYT
$4.77B
| $19.9M | 0.83% |
2,133,500
| – | – |
|
|
GTT
49
DELISTED
GTT Communications, Inc.
GTT
| $19.8M | 0.82% |
441,000
| – | – |
|
|
PFPT
50
DELISTED
Proofpoint, Inc.
PFPT
| $18.2M | 0.76% |
158,000
| – | – |
|
Similar funds
HPG
EMPI
RCG
JWBC
AAM
AA
CM
CIS
Eventide Asset Management's Q2 2018 Portfolio in Review
As of Q2 2018, Eventide Asset Management held 158 positions worth $2.41B, up 13% from $2.14B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Eventide Asset Management deployed $112M of net new capital in Q2 2018, opening 13 new positions and adding to 40 existing holdings. Its largest new stake was Dianthus Therapeutics: 139,881 shares worth $29.5M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Snap-on, an estimated $10.6M trimmed.
- Eventide Asset Management's largest Q2 2018 buy was Dianthus Therapeutics: 139,881 shares worth $29.5M.
- Eventide Asset Management added most to Myovant Sciences Ltd. in Q2 2018, an estimated $22.5M increase.
- Eventide Asset Management's biggest Q2 2018 reduction was Snap-on, cutting an estimated $10.6M.
- Eventide Asset Management fully exited AveXis, Inc. Common Stock in Q2 2018, selling an estimated $52M.
- Eventide Asset Management's ten largest holdings make up 25% of its $2.41B portfolio in Q2 2018.
- Eventide Asset Management opened 13 new positions and closed 14 in Q2 2018.
- Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $2.41B.
Based on Eventide Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.